Lazard Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.84M | Sell |
|
|||||
|
2025
Q2 | $2.45M | Buy |
|
|||||
|
2025
Q1 | $570K | Buy |
|
|||||
|
2024
Q4 | $339K | Sell |
|
|||||
|
2024
Q3 | $362K | Sell |
|
|||||
|
2024
Q2 | $35.5M | Buy |
|
|||||
|
2024
Q1 | $8.95M | Buy |
|
|||||
|
2023
Q4 | $3.76M | Sell |
|
|||||
|
2023
Q3 | $16.6M | Sell |
|
|||||
|
2023
Q2 | $44.6M | Buy |
|
|||||
|
2023
Q1 | $8.74M | Buy |
|
|||||
|
2022
Q4 | $547K | Sell |
|
|||||
|
2022
Q3 | $630K | Sell |
|
|||||
|
2022
Q2 | $4.84M | Buy |
|
|||||
|
2022
Q1 | $767K | Sell |
|
|||||
|
2021
Q4 | $947K | Sell |
|
|||||
|
2021
Q3 | $3.08M | Buy |
|
|||||
|
2021
Q2 | $646K | Sell |
|
|||||
|
2021
Q1 | $836K | Sell |
|
|||||
|
2020
Q4 | $48.2M | Sell |
|
|||||
|
2020
Q3 | $48.3M | Buy |
|
|||||
|
2020
Q2 | $38M | Buy |
|
|||||
|
2020
Q1 | $23.1M | Buy |
|
|||||
|
2019
Q4 | $27.2M | Buy |
|
|||||
|
2019
Q3 | $5.44M | Buy |
|
|||||
|
2019
Q2 | $3.54M | Sell |
|
|||||
|
2019
Q1 | $4.46M | Buy |
|
|||||
|
2018
Q4 | $2.76M | Sell |
|
|||||
|
2018
Q3 | $7.67M | Sell |
|
|||||
|
2018
Q2 | $6.47M | Buy |
|
|||||
|
2018
Q1 | $1.4M | Buy |
|
|||||
|
2017
Q4 | $2K | Hold |
|
|||||
|
2017
Q3 | $1K | Sell |
|
|||||
|
2017
Q2 | $211K | Sell |
|
|||||
|
2017
Q1 | $894K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $2.17M | Sell |
|
|||||
|
2015
Q2 | $5.21M | Sell |
|
|||||
|
2015
Q1 | $8.47M | Sell |
|
|||||
|
2014
Q4 | $10M | Sell |
|
|||||
|
2014
Q3 | $9.36M | Buy |
|